Clinical Trial Update: The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether POMX, a natural pomegranate polyphenolic extract, affects the development of atherosclerosis in diabetic patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Diabetes Mellitus

Drugs mentioned

• POMX (pomegranate polyphenolic extract)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Atherosclerosis | Phase 4 | Status: UNKNOWN